# OnCo record conjunctival-melanoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/conjunctival-melanoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "conjunctival-melanoma" ;
  schema:name "Conjunctival melanoma"@en ;
  schema:alternateName "Melanoma of the conjunctiva"@en, "Ocular surface melanoma"@en, "Conjunctival malignant melanoma"@en ;
  schema:description "Conjunctival melanoma is a rare melanoma of the clear membrane over the white of the eye, usually growing out of a flat brown patch called primary acquired melanosis. It is removed with a margin and the edges frozen or treated with chemotherapy drops; about one in five spread within five years, and advanced disease is treated like skin melanoma with targeted or immune drugs."@en ;
  schema:url <https://onco.cc/cancers/conjunctival-melanoma/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Conjunctival_melanoma> ;
  schema:citation <https://www.cancer.gov/types/eye/patient/intraocular-melanoma-treatment-pdq>, <https://doi.org/10.1016/j.ophtha.2010.06.021>, <https://doi.org/10.1111/aos.13007> ;
  onco:tag "subtype-page", "wave4", "rare" ;
  onco:related <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/uveal-melanoma/>, <https://onco.cc/cancers/mucosal-melanoma/>, <https://onco.cc/cancers/acral-melanoma/> ;
  onco:targets <https://onco.cc/targets/braf/> ;
  onco:drugs <https://onco.cc/drugs/mitomycin/>, <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:standardOfCare <https://onco.cc/cancers/melanoma/>, <https://onco.cc/drugs/mitomycin/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/> .